Acadia Healthcare Inc. (ACHC)
44.29
-1.12 (-2.47%)
At close: Jan 14, 2025, 3:59 PM
44.37
0.18%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 37.35 |
| Market Cap | 4.11B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 3.05 |
| PE Ratio (ttm) | 14.52 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 46.77 |
| Volume | 1,635,112 |
| Avg. Volume (20D) | 1,790,403 |
| Open | 45.33 |
| Previous Close | 45.41 |
| Day's Range | 42.98 - 45.62 |
| 52-Week Range | 36.50 - 87.77 |
| Beta | undefined |
About ACHC
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The com...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Mar 4, 1994
Employees 17,000
Stock Exchange NASDAQ
Ticker Symbol ACHC
Website https://www.acadiahealthcare.com
Analyst Forecast
According to 9 analyst ratings, the average rating for ACHC stock is "Buy." The 12-month stock price forecast is $70, which is an increase of 58.05% from the latest price.
Buy 66.67%
Hold 22.22%
Sell 0.00%
Next Earnings Release
Acadia Healthcare Inc. is scheduled to release its earnings on Feb 25, 2025,
during market hours.
Analysts project revenue of $779.71M, reflecting a 4.97% YoY growth and earnings per share of 0.72, making a -17.24% decrease YoY.
Analysts project revenue of $779.71M, reflecting a 4.97% YoY growth and earnings per share of 0.72, making a -17.24% decrease YoY.
2 months ago ·
Source
-18.03%
Acadia Healthcare shares are trading lower after t...
Unlock content with
Pro Subscription
2 months ago ·
Source
+0.93%
Acadia Healthcare shares are trading lower after the company reported worse-than-expected Q3 revenue results and issued FY24 guidance below estimates.
